The PTP4A3 Inhibitor KVX-053 Prevents Lung Injury Induced by High Tidal Volume Ventilation in Mice

Mechanical ventilation is a life-saving intervention in acute respiratory failure but can precipitate venti-lator-induced lung injury (VILI) through volutrauma, barotrauma, and biotrauma. In this study, we hypothesized that intravenous injection of KVX-053, a protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) inhibitor, could mitigate lung injury following high tidal ventilation (HTV). Male and female mice were anesthetized with ketamine/xylazine mix (20-50 mg/kg and 3-5 mg/kg), connected to a FlexiVent small animal ventilator (SCIREQ) and ventilated at standard tidal ventilation (STV, 10 mL/Kg) or HTV (30 mL/Kg) for 4 hours. Two additional groups were subjected to HTV and received KVX-053 (1 mg/kg iv) either 30 minutes before or after the beginning of the ventilation. During ventilation, a complete set of respiratory parameters was collected hourly. After 4 hours, mice were euthanized, bronchoalveolar lavage fluid collected for cellularity and cytokine/chemokine expression and lungs harvested for wet-to-dry ratio, molecular and histological analyses. KVX-053 preserved dynamic and static compli-ances (Cst/Crs), attenuated HTV-induced increases in respiratory resistances (Rrs, G, Ers), reduced al-veolar cellularity and proteinosis, lowered wet-to-dry lung weight ratios, and improved histological ar-chitecture. Furthermore, KVX-053 suppressed STAT3 and IκBα phosphorylation, prevented the HTV-mediated cytokine surge involving IL-1/TNF, IFN-γ axis mediators, IL-2/IL-15, Th2, and Th17, restored SHP-2 expression, decreased TGF-β1 mRNA levels, and normalized VEGF expression toward control values. These findings indicate that KVX-053 administered iv at 1 mg/kg did not produce ob-servable acute adverse effects and, in both pre- and post-treatment paradigms, mitigated both biotrauma and volutrauma following HTV.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-16
DOI
https://doi.org/10.20944/preprints202611.1503.v1
Primary Topic
Respiratory Support and Mechanisms
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The PTP4A3 Inhibitor KVX-053 Prevents Lung Injury Induced by High Tidal Volume Ventilation in Mice

Tierney Day, John D. Catravas, Elizabeth R. Sharlow, John S. Lazo et al.
1 links
Preprints.org
Respiratory Support and Mechanisms
preprint

The PTP4A3 Inhibitor KVX-053 Prevents Lung Injury Induced by High Tidal Volume Ventilation in Mice

Tierney Day, John D. Catravas, Elizabeth R. Sharlow, John S. Lazo, Ruben M. L. Colunga-Biancatelli, Pavel A. Solopov, Alicia Yu-Shan, Connor Meek
preprint en

Abstract

Mechanical ventilation is a life-saving intervention in acute respiratory failure but can precipitate venti-lator-induced lung injury (VILI) through volutrauma, barotrauma, and biotrauma. In this study, we hypothesized that intravenous injection of KVX-053, a protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) inhibitor, could mitigate lung injury following high tidal ventilation (HTV). Male and female mice were anesthetized with ketamine/xylazine mix (20-50 mg/kg and 3-5 mg/kg), connected to a FlexiVent small animal ventilator (SCIREQ) and ventilated at standard tidal ventilation (STV, 10 mL/Kg) or HTV (30 mL/Kg) for 4 hours. Two additional groups were subjected to HTV and received KVX-053 (1 mg/kg iv) either 30 minutes before or after the beginning of the ventilation. During ventilation, a complete set of respiratory parameters was collected hourly. After 4 hours, mice were euthanized, bronchoalveolar lavage fluid collected for cellularity and cytokine/chemokine expression and lungs harvested for wet-to-dry ratio, molecular and histological analyses. KVX-053 preserved dynamic and static compli-ances (Cst/Crs), attenuated HTV-induced increases in respiratory resistances (Rrs, G, Ers), reduced al-veolar cellularity and proteinosis, lowered wet-to-dry lung weight ratios, and improved histological ar-chitecture. Furthermore, KVX-053 suppressed STAT3 and IκBα phosphorylation, prevented the HTV-mediated cytokine surge involving IL-1/TNF, IFN-γ axis mediators, IL-2/IL-15, Th2, and Th17, restored SHP-2 expression, decreased TGF-β1 mRNA levels, and normalized VEGF expression toward control values. These findings indicate that KVX-053 administered iv at 1 mg/kg did not produce ob-servable acute adverse effects and, in both pre- and post-treatment paradigms, mitigated both biotrauma and volutrauma following HTV.

Preprints.org
Good health and well-being
Respiratory Support and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon